论文部分内容阅读
目的:探讨高龄原发性肝癌切除术后行肝动脉化疗栓塞联合复方苦参注射液治疗的临床疗效。方法:将98例原发性肝癌切除术后高龄患者随机分为两组,在手术切除肝肿瘤后并行常规治疗的基础上,治疗组加用肝动脉介入化疗栓塞术并按疗程静脉滴注复方苦参注射液,对照组仅用肝动脉介入化疗栓塞术疗法,观察上述两组患者的症状体征、肝功能、甲胎蛋白变化及生存率情况。结果:治疗组患者的临床症状、肝功能、甲胎蛋白及治疗后生存时间均明显优于对照组,两者差异有统计学意义(P<0.01)。结论:高龄原发性肝癌切除术后行肝动脉化疗栓塞联合复方苦参注射液治疗的疗效显著,可作为治疗高龄原发性肝癌的主要治疗方案并可在临床中推广应用。
Objective: To investigate the clinical efficacy of transcatheter arterial chemoembolization combined with compound Kushen injection after advanced hepatic cancer resection. Methods: A total of 98 patients with primary liver cancer after resection were randomly divided into two groups. After surgical resection of the liver tumor and routine treatment, the treatment group was treated with hepatic artery interventional chemotherapy and embolization and treated with intravenous infusion of compound prescription Oxymatrine injection, the control group only with hepatic artery interventional chemotherapy and embolization therapy to observe the above two groups of patients with signs and symptoms, liver function, alpha-fetoprotein changes and survival rates. Results: The clinical symptoms, liver function, alpha-fetoprotein, and survival time after treatment in the treatment group were significantly better than those in the control group. The difference was statistically significant (P <0.01). Conclusion: The curative effect of hepatic arterial chemoembolization combined with Compound Kushen Injection after advanced hepatic cancer resection is significant. It can be used as the main treatment for the treatment of advanced primary liver cancer and can be widely used in clinic.